Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferences

• Egile Nagusiak: Marloes Dankers (Egilea), Marjorie H. J. M. G. Nelissen‐Vrancken (Egilea), Bertien H. Hart (Egilea), Anke C. Lambooij (Egilea), Liset vanDijk (Egilea), Aukje K. Mantel‐Teeuwisse (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2021-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract To evaluate the clinical benefit of new medicines for type 2 diabetes mellitus (T2DM), the Dutch guideline committee T2DM in primary care established the importance of outcomes and minimal clinically important differences (MCIDs). The present study used an online questionnaire to investigat...